BANK VONTOBEL/CALL/NOVARTIS N/90/0.1/20.09.24 Share Price

Warrant

DE000VM3V6Z1

Market Closed - Deutsche Boerse AG 18:43:38 05/07/2024 BST
0.83 EUR -4.60% Intraday chart for BANK VONTOBEL/CALL/NOVARTIS N/90/0.1/20.09.24
Current month+5.06%
1 month+23.88%
Date Price Change
05/07/24 0.83 -4.60%
04/07/24 0.87 +12.99%
03/07/24 0.77 -3.75%
02/07/24 0.8 -2.44%
01/07/24 0.82 +3.80%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 06:43 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer Vontobel Vontobel
WKN VM3V6Z
ISINDE000VM3V6Z1
Date issued 11/10/2023
Strike 90 CHF
Maturity 20/09/2024 (76 Days)
Parity 10 : 1
Emission price 0.57
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.88
Lowest since issue 0.195
Delta0.75x
Omega 8.192
Premium2.26x
Gearing10.99x
Moneyness 1.073
Difference Strike -6.61 CHF
Difference Strike %-7.34%
Spread 0.13
Spread %13.40%
Intrinsic value 0.6804

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
107.7 USD
Average target price
111 USD
Spread / Average Target
+3.13%
Consensus